nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprost Tromethamine—PTGIR—pulmonary artery—sarcoma	0.0495	0.107	CbGeAlD
Dinoprost Tromethamine—TBXA2R—endothelium—sarcoma	0.0286	0.0616	CbGeAlD
Dinoprost Tromethamine—GALR3—uterus—sarcoma	0.0179	0.0386	CbGeAlD
Dinoprost Tromethamine—PTGER3—mammary gland—sarcoma	0.0177	0.0382	CbGeAlD
Dinoprost Tromethamine—PTGIR—endothelium—sarcoma	0.0155	0.0334	CbGeAlD
Dinoprost Tromethamine—TBXA2R—hematopoietic system—sarcoma	0.014	0.0303	CbGeAlD
Dinoprost Tromethamine—PTGER3—myometrium—sarcoma	0.0126	0.0271	CbGeAlD
Dinoprost Tromethamine—HPGDS—myometrium—sarcoma	0.0109	0.0234	CbGeAlD
Dinoprost Tromethamine—HPGDS—embryo—sarcoma	0.0105	0.0225	CbGeAlD
Dinoprost Tromethamine—PTGER3—connective tissue—sarcoma	0.0104	0.0224	CbGeAlD
Dinoprost Tromethamine—PTGFR—myometrium—sarcoma	0.0101	0.0217	CbGeAlD
Dinoprost Tromethamine—PTGER3—smooth muscle tissue—sarcoma	0.00952	0.0205	CbGeAlD
Dinoprost Tromethamine—HPGDS—hematopoietic system—sarcoma	0.00934	0.0201	CbGeAlD
Dinoprost Tromethamine—HPGDS—connective tissue—sarcoma	0.00899	0.0194	CbGeAlD
Dinoprost Tromethamine—PTGER3—uterus—sarcoma	0.00816	0.0176	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—myometrium—sarcoma	0.00783	0.0169	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—myometrium—sarcoma	0.00775	0.0167	CbGeAlD
Dinoprost Tromethamine—TBXA2R—testis—sarcoma	0.00769	0.0166	CbGeAlD
Dinoprost Tromethamine—PTGIR—hematopoietic system—sarcoma	0.00762	0.0164	CbGeAlD
Dinoprost Tromethamine—PTGFR—smooth muscle tissue—sarcoma	0.00761	0.0164	CbGeAlD
Dinoprost Tromethamine—PTGIR—connective tissue—sarcoma	0.00733	0.0158	CbGeAlD
Dinoprost Tromethamine—TBXA2R—liver—sarcoma	0.00727	0.0157	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—seminal vesicle—sarcoma	0.00707	0.0152	CbGeAlD
Dinoprost Tromethamine—HPGDS—uterus—sarcoma	0.00706	0.0152	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—seminal vesicle—sarcoma	0.007	0.0151	CbGeAlD
Dinoprost Tromethamine—PTGIR—smooth muscle tissue—sarcoma	0.00671	0.0145	CbGeAlD
Dinoprost Tromethamine—HPGDS—lymphoid tissue—sarcoma	0.00658	0.0142	CbGeAlD
Dinoprost Tromethamine—PTGFR—uterus—sarcoma	0.00653	0.0141	CbGeAlD
Dinoprost Tromethamine—HPGDS—tendon—sarcoma	0.00618	0.0133	CbGeAlD
Dinoprost Tromethamine—HPGDS—bone marrow—sarcoma	0.00599	0.0129	CbGeAlD
Dinoprost Tromethamine—PTGER3—testis—sarcoma	0.00592	0.0128	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—skin of body—sarcoma	0.00579	0.0125	CbGeAlD
Dinoprost Tromethamine—PTGFR—tendon—sarcoma	0.00572	0.0123	CbGeAlD
Dinoprost Tromethamine—TBXA2R—lymph node—sarcoma	0.00558	0.012	CbGeAlD
Dinoprost Tromethamine—HPGDS—testis—sarcoma	0.00512	0.011	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—cardiac atrium—sarcoma	0.0051	0.011	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—cardiac atrium—sarcoma	0.00505	0.0109	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—uterus—sarcoma	0.00503	0.0108	CbGeAlD
Dinoprost Tromethamine—HPGDS—liver—sarcoma	0.00484	0.0104	CbGeAlD
Dinoprost Tromethamine—PTGFR—testis—sarcoma	0.00474	0.0102	CbGeAlD
Dinoprost Tromethamine—PTGFR—liver—sarcoma	0.00448	0.00965	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—tendon—sarcoma	0.00445	0.00958	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—tendon—sarcoma	0.00441	0.00949	CbGeAlD
Dinoprost Tromethamine—PTGER3—lymph node—sarcoma	0.00429	0.00925	CbGeAlD
Dinoprost Tromethamine—SLC22A8—hematopoietic system—sarcoma	0.00419	0.00902	CbGeAlD
Dinoprost Tromethamine—PTGIR—testis—sarcoma	0.00417	0.00899	CbGeAlD
Dinoprost Tromethamine—SLC22A7—testis—sarcoma	0.00397	0.00855	CbGeAlD
Dinoprost Tromethamine—PTGIR—liver—sarcoma	0.00395	0.0085	CbGeAlD
Dinoprost Tromethamine—SLC22A11—liver—sarcoma	0.00384	0.00828	CbGeAlD
Dinoprost Tromethamine—SLC22A7—liver—sarcoma	0.00375	0.00809	CbGeAlD
Dinoprost Tromethamine—HPGDS—lymph node—sarcoma	0.00371	0.008	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—testis—sarcoma	0.00368	0.00794	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—testis—sarcoma	0.00365	0.00786	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—liver—sarcoma	0.00348	0.0075	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—liver—sarcoma	0.00345	0.00743	CbGeAlD
Dinoprost Tromethamine—PTGFR—lymph node—sarcoma	0.00343	0.0074	CbGeAlD
Dinoprost Tromethamine—PTGIR—lymph node—sarcoma	0.00303	0.00652	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—lymph node—sarcoma	0.00267	0.00575	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—lymph node—sarcoma	0.00264	0.0057	CbGeAlD
Dinoprost Tromethamine—Extravasation—Epirubicin—sarcoma	0.00256	0.00511	CcSEcCtD
Dinoprost Tromethamine—Haematuria—Mitoxantrone—sarcoma	0.00256	0.0051	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Thiotepa—sarcoma	0.00253	0.00504	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Thiotepa—sarcoma	0.00252	0.00502	CcSEcCtD
Dinoprost Tromethamine—Petechiae—Doxorubicin—sarcoma	0.00252	0.00501	CcSEcCtD
Dinoprost Tromethamine—Chills—Thiotepa—sarcoma	0.0025	0.00499	CcSEcCtD
Dinoprost Tromethamine—Chills—Dactinomycin—sarcoma	0.00248	0.00495	CcSEcCtD
Dinoprost Tromethamine—Bronchospasm—Etoposide—sarcoma	0.00246	0.0049	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Mitoxantrone—sarcoma	0.00245	0.00488	CcSEcCtD
Dinoprost Tromethamine—Extravasation—Doxorubicin—sarcoma	0.00237	0.00472	CcSEcCtD
Dinoprost Tromethamine—Back pain—Thiotepa—sarcoma	0.00235	0.00468	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Vincristine—sarcoma	0.00224	0.00447	CcSEcCtD
Dinoprost Tromethamine—Hiccups—Epirubicin—sarcoma	0.00224	0.00445	CcSEcCtD
Dinoprost Tromethamine—Pulmonary embolism—Epirubicin—sarcoma	0.00224	0.00445	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Dactinomycin—sarcoma	0.00224	0.00445	CcSEcCtD
Dinoprost Tromethamine—Agitation—Thiotepa—sarcoma	0.00223	0.00444	CcSEcCtD
Dinoprost Tromethamine—Malaise—Dactinomycin—sarcoma	0.00217	0.00433	CcSEcCtD
Dinoprost Tromethamine—Chills—Mitoxantrone—sarcoma	0.00216	0.0043	CcSEcCtD
Dinoprost Tromethamine—Cough—Thiotepa—sarcoma	0.00212	0.00422	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Thiotepa—sarcoma	0.0021	0.00419	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Thiotepa—sarcoma	0.0021	0.00418	CcSEcCtD
Dinoprost Tromethamine—Back pain—Vincristine—sarcoma	0.00208	0.00415	CcSEcCtD
Dinoprost Tromethamine—Pulmonary embolism—Doxorubicin—sarcoma	0.00207	0.00412	CcSEcCtD
Dinoprost Tromethamine—Hiccups—Doxorubicin—sarcoma	0.00207	0.00412	CcSEcCtD
Dinoprost Tromethamine—Back pain—Mitoxantrone—sarcoma	0.00203	0.00404	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Dactinomycin—sarcoma	0.00203	0.00404	CcSEcCtD
Dinoprost Tromethamine—Agitation—Vincristine—sarcoma	0.00198	0.00394	CcSEcCtD
Dinoprost Tromethamine—Infection—Thiotepa—sarcoma	0.00197	0.00392	CcSEcCtD
Dinoprost Tromethamine—Hypertonia—Epirubicin—sarcoma	0.00196	0.0039	CcSEcCtD
Dinoprost Tromethamine—Infection—Dactinomycin—sarcoma	0.00195	0.00389	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Mitoxantrone—sarcoma	0.00195	0.00388	CcSEcCtD
Dinoprost Tromethamine—Sepsis—Epirubicin—sarcoma	0.00194	0.00387	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Thiotepa—sarcoma	0.00193	0.00385	CcSEcCtD
Dinoprost Tromethamine—Malaise—Mitoxantrone—sarcoma	0.00189	0.00377	CcSEcCtD
Dinoprost Tromethamine—Phlebitis—Epirubicin—sarcoma	0.00188	0.00375	CcSEcCtD
Dinoprost Tromethamine—Thrombophlebitis—Epirubicin—sarcoma	0.00188	0.00374	CcSEcCtD
Dinoprost Tromethamine—Diabetes mellitus—Epirubicin—sarcoma	0.00187	0.00372	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Vincristine—sarcoma	0.00187	0.00372	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Vincristine—sarcoma	0.00186	0.0037	CcSEcCtD
Dinoprost Tromethamine—Cough—Mitoxantrone—sarcoma	0.00183	0.00364	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Etoposide—sarcoma	0.00182	0.00362	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Mitoxantrone—sarcoma	0.00182	0.00362	CcSEcCtD
Dinoprost Tromethamine—Hypertonia—Doxorubicin—sarcoma	0.00181	0.00361	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Mitoxantrone—sarcoma	0.00181	0.00361	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Etoposide—sarcoma	0.00181	0.0036	CcSEcCtD
Dinoprost Tromethamine—Chills—Etoposide—sarcoma	0.0018	0.00358	CcSEcCtD
Dinoprost Tromethamine—Sepsis—Doxorubicin—sarcoma	0.0018	0.00358	CcSEcCtD
Dinoprost Tromethamine—Cardiac failure congestive—Epirubicin—sarcoma	0.00179	0.00357	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Mitoxantrone—sarcoma	0.00179	0.00356	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Thiotepa—sarcoma	0.00178	0.00354	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Mitoxantrone—sarcoma	0.00176	0.00351	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Thiotepa—sarcoma	0.00176	0.00351	CcSEcCtD
Dinoprost Tromethamine—Infection—Vincristine—sarcoma	0.00175	0.00348	CcSEcCtD
Dinoprost Tromethamine—Phlebitis—Doxorubicin—sarcoma	0.00174	0.00347	CcSEcCtD
Dinoprost Tromethamine—Thrombophlebitis—Doxorubicin—sarcoma	0.00174	0.00346	CcSEcCtD
Dinoprost Tromethamine—Diabetes mellitus—Doxorubicin—sarcoma	0.00173	0.00344	CcSEcCtD
Dinoprost Tromethamine—Infection—Mitoxantrone—sarcoma	0.0017	0.00339	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Vincristine—sarcoma	0.0017	0.00338	CcSEcCtD
Dinoprost Tromethamine—Pain—Thiotepa—sarcoma	0.00169	0.00338	CcSEcCtD
Dinoprost Tromethamine—Back pain—Etoposide—sarcoma	0.00169	0.00336	CcSEcCtD
Dinoprost Tromethamine—Shock—Mitoxantrone—sarcoma	0.00168	0.00335	CcSEcCtD
Dinoprost Tromethamine—Pain—Dactinomycin—sarcoma	0.00168	0.00335	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Etoposide—sarcoma	0.00168	0.00334	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Mitoxantrone—sarcoma	0.00167	0.00333	CcSEcCtD
Dinoprost Tromethamine—Cardiac failure congestive—Doxorubicin—sarcoma	0.00166	0.0033	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Mitoxantrone—sarcoma	0.00165	0.0033	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Vincristine—sarcoma	0.00164	0.00327	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Thiotepa—sarcoma	0.00163	0.00325	CcSEcCtD
Dinoprost Tromethamine—Diplopia—Epirubicin—sarcoma	0.00162	0.00323	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Dactinomycin—sarcoma	0.00162	0.00323	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Thiotepa—sarcoma	0.00162	0.00323	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Etoposide—sarcoma	0.00162	0.00322	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Dactinomycin—sarcoma	0.00161	0.0032	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Mitoxantrone—sarcoma	0.0016	0.00319	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Vincristine—sarcoma	0.00158	0.00314	CcSEcCtD
Dinoprost Tromethamine—Malaise—Etoposide—sarcoma	0.00157	0.00313	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Thiotepa—sarcoma	0.00157	0.00312	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Thiotepa—sarcoma	0.00157	0.00312	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Dactinomycin—sarcoma	0.00155	0.0031	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Dactinomycin—sarcoma	0.00155	0.0031	CcSEcCtD
Dinoprost Tromethamine—Cardiac arrest—Epirubicin—sarcoma	0.00154	0.00307	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Mitoxantrone—sarcoma	0.00154	0.00306	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Etoposide—sarcoma	0.00153	0.00305	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Mitoxantrone—sarcoma	0.00153	0.00304	CcSEcCtD
Dinoprost Tromethamine—Cough—Etoposide—sarcoma	0.00152	0.00303	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Mitoxantrone—sarcoma	0.00152	0.00303	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Etoposide—sarcoma	0.00151	0.00301	CcSEcCtD
Dinoprost Tromethamine—Dehydration—Epirubicin—sarcoma	0.00151	0.00301	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Etoposide—sarcoma	0.00151	0.003	CcSEcCtD
Dinoprost Tromethamine—Pain—Vincristine—sarcoma	0.0015	0.00299	CcSEcCtD
Dinoprost Tromethamine—Diplopia—Doxorubicin—sarcoma	0.0015	0.00299	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Etoposide—sarcoma	0.00148	0.00296	CcSEcCtD
Dinoprost Tromethamine—Hypokalaemia—Epirubicin—sarcoma	0.00148	0.00294	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Etoposide—sarcoma	0.00147	0.00292	CcSEcCtD
Dinoprost Tromethamine—Pain—Mitoxantrone—sarcoma	0.00146	0.00291	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Thiotepa—sarcoma	0.00146	0.00291	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Dactinomycin—sarcoma	0.00145	0.00289	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Vincristine—sarcoma	0.00144	0.00286	CcSEcCtD
Dinoprost Tromethamine—Cardiac arrest—Doxorubicin—sarcoma	0.00143	0.00285	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Thiotepa—sarcoma	0.00142	0.00283	CcSEcCtD
Dinoprost Tromethamine—Infection—Etoposide—sarcoma	0.00141	0.00282	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Dactinomycin—sarcoma	0.00141	0.00281	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Mitoxantrone—sarcoma	0.00141	0.00281	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Thiotepa—sarcoma	0.0014	0.00279	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.0014	0.00279	CcSEcCtD
Dinoprost Tromethamine—Dehydration—Doxorubicin—sarcoma	0.0014	0.00278	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Etoposide—sarcoma	0.00139	0.00277	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Vincristine—sarcoma	0.00139	0.00277	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Vincristine—sarcoma	0.00139	0.00277	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Etoposide—sarcoma	0.00138	0.00274	CcSEcCtD
Dinoprost Tromethamine—Hypokalaemia—Doxorubicin—sarcoma	0.00137	0.00272	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Thiotepa—sarcoma	0.00136	0.0027	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Mitoxantrone—sarcoma	0.00135	0.00269	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Mitoxantrone—sarcoma	0.00135	0.00269	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Dactinomycin—sarcoma	0.00135	0.00268	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Etoposide—sarcoma	0.00133	0.00265	CcSEcCtD
Dinoprost Tromethamine—Dysuria—Epirubicin—sarcoma	0.00131	0.00261	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Thiotepa—sarcoma	0.00131	0.00261	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Vincristine—sarcoma	0.00129	0.00258	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Etoposide—sarcoma	0.00128	0.00255	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Etoposide—sarcoma	0.00127	0.00253	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Etoposide—sarcoma	0.00127	0.00252	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Mitoxantrone—sarcoma	0.00126	0.00251	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Vincristine—sarcoma	0.00126	0.00251	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Thiotepa—sarcoma	0.00126	0.00251	CcSEcCtD
Dinoprost Tromethamine—Drowsiness—Epirubicin—sarcoma	0.00125	0.00249	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Dactinomycin—sarcoma	0.00125	0.00249	CcSEcCtD
Dinoprost Tromethamine—Rash—Thiotepa—sarcoma	0.00125	0.00249	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Thiotepa—sarcoma	0.00125	0.00249	CcSEcCtD
Dinoprost Tromethamine—Headache—Thiotepa—sarcoma	0.00124	0.00247	CcSEcCtD
Dinoprost Tromethamine—Rash—Dactinomycin—sarcoma	0.00124	0.00247	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Mitoxantrone—sarcoma	0.00123	0.00245	CcSEcCtD
Dinoprost Tromethamine—Pain—Etoposide—sarcoma	0.00122	0.00242	CcSEcCtD
Dinoprost Tromethamine—Urinary tract infection—Epirubicin—sarcoma	0.00122	0.00242	CcSEcCtD
Dinoprost Tromethamine—Dysuria—Doxorubicin—sarcoma	0.00121	0.00242	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Vincristine—sarcoma	0.0012	0.00239	CcSEcCtD
Dinoprost Tromethamine—Sweating—Epirubicin—sarcoma	0.0012	0.00239	CcSEcCtD
Dinoprost Tromethamine—Haematuria—Epirubicin—sarcoma	0.00119	0.00238	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Epirubicin—sarcoma	0.00118	0.00235	CcSEcCtD
Dinoprost Tromethamine—Nausea—Thiotepa—sarcoma	0.00118	0.00234	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Etoposide—sarcoma	0.00117	0.00234	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Mitoxantrone—sarcoma	0.00117	0.00233	CcSEcCtD
Dinoprost Tromethamine—Nausea—Dactinomycin—sarcoma	0.00117	0.00233	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Etoposide—sarcoma	0.00116	0.00232	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Vincristine—sarcoma	0.00116	0.00231	CcSEcCtD
Dinoprost Tromethamine—Drowsiness—Doxorubicin—sarcoma	0.00116	0.00231	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Epirubicin—sarcoma	0.00114	0.00228	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Etoposide—sarcoma	0.00113	0.00224	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Etoposide—sarcoma	0.00113	0.00224	CcSEcCtD
Dinoprost Tromethamine—Urinary tract infection—Doxorubicin—sarcoma	0.00113	0.00224	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Vincristine—sarcoma	0.00112	0.00223	CcSEcCtD
Dinoprost Tromethamine—Sweating—Doxorubicin—sarcoma	0.00111	0.00221	CcSEcCtD
Dinoprost Tromethamine—Rash—Vincristine—sarcoma	0.00111	0.00221	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Vincristine—sarcoma	0.00111	0.0022	CcSEcCtD
Dinoprost Tromethamine—Haematuria—Doxorubicin—sarcoma	0.0011	0.0022	CcSEcCtD
Dinoprost Tromethamine—Headache—Vincristine—sarcoma	0.0011	0.00219	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Doxorubicin—sarcoma	0.00109	0.00217	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Mitoxantrone—sarcoma	0.00109	0.00217	CcSEcCtD
Dinoprost Tromethamine—Rash—Mitoxantrone—sarcoma	0.00108	0.00215	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Mitoxantrone—sarcoma	0.00108	0.00215	CcSEcCtD
Dinoprost Tromethamine—Headache—Mitoxantrone—sarcoma	0.00107	0.00214	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Doxorubicin—sarcoma	0.00106	0.00211	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Etoposide—sarcoma	0.00105	0.00209	CcSEcCtD
Dinoprost Tromethamine—Nausea—Vincristine—sarcoma	0.00104	0.00208	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Etoposide—sarcoma	0.00102	0.00203	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Epirubicin—sarcoma	0.00102	0.00203	CcSEcCtD
Dinoprost Tromethamine—Nausea—Mitoxantrone—sarcoma	0.00102	0.00202	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Epirubicin—sarcoma	0.00101	0.00202	CcSEcCtD
Dinoprost Tromethamine—Chills—Epirubicin—sarcoma	0.00101	0.00201	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Etoposide—sarcoma	0.00101	0.00201	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Etoposide—sarcoma	0.000974	0.00194	CcSEcCtD
Dinoprost Tromethamine—Back pain—Epirubicin—sarcoma	0.000946	0.00188	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Doxorubicin—sarcoma	0.000943	0.00188	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Etoposide—sarcoma	0.000941	0.00187	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Epirubicin—sarcoma	0.00094	0.00187	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Doxorubicin—sarcoma	0.000939	0.00187	CcSEcCtD
Dinoprost Tromethamine—Chills—Doxorubicin—sarcoma	0.000932	0.00186	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Epirubicin—sarcoma	0.000907	0.00181	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Etoposide—sarcoma	0.000905	0.0018	CcSEcCtD
Dinoprost Tromethamine—Agitation—Epirubicin—sarcoma	0.000898	0.00179	CcSEcCtD
Dinoprost Tromethamine—Rash—Etoposide—sarcoma	0.000898	0.00179	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Etoposide—sarcoma	0.000897	0.00179	CcSEcCtD
Dinoprost Tromethamine—Headache—Etoposide—sarcoma	0.000892	0.00178	CcSEcCtD
Dinoprost Tromethamine—Malaise—Epirubicin—sarcoma	0.000882	0.00176	CcSEcCtD
Dinoprost Tromethamine—Syncope—Epirubicin—sarcoma	0.000877	0.00175	CcSEcCtD
Dinoprost Tromethamine—Back pain—Doxorubicin—sarcoma	0.000875	0.00174	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Doxorubicin—sarcoma	0.00087	0.00173	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Epirubicin—sarcoma	0.000859	0.00171	CcSEcCtD
Dinoprost Tromethamine—Cough—Epirubicin—sarcoma	0.000853	0.0017	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Epirubicin—sarcoma	0.000847	0.00169	CcSEcCtD
Dinoprost Tromethamine—Nausea—Etoposide—sarcoma	0.000846	0.00168	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Epirubicin—sarcoma	0.000844	0.00168	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Doxorubicin—sarcoma	0.000839	0.00167	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Epirubicin—sarcoma	0.000832	0.00166	CcSEcCtD
Dinoprost Tromethamine—Agitation—Doxorubicin—sarcoma	0.000831	0.00166	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Epirubicin—sarcoma	0.000822	0.00164	CcSEcCtD
Dinoprost Tromethamine—Malaise—Doxorubicin—sarcoma	0.000816	0.00162	CcSEcCtD
Dinoprost Tromethamine—Syncope—Doxorubicin—sarcoma	0.000811	0.00162	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Doxorubicin—sarcoma	0.000795	0.00158	CcSEcCtD
Dinoprost Tromethamine—Infection—Epirubicin—sarcoma	0.000793	0.00158	CcSEcCtD
Dinoprost Tromethamine—Cough—Doxorubicin—sarcoma	0.000789	0.00157	CcSEcCtD
Dinoprost Tromethamine—Shock—Epirubicin—sarcoma	0.000785	0.00156	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Doxorubicin—sarcoma	0.000784	0.00156	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Doxorubicin—sarcoma	0.000781	0.00156	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Epirubicin—sarcoma	0.000779	0.00155	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Epirubicin—sarcoma	0.000771	0.00154	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Doxorubicin—sarcoma	0.00077	0.00153	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Doxorubicin—sarcoma	0.000761	0.00152	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Epirubicin—sarcoma	0.000746	0.00149	CcSEcCtD
Dinoprost Tromethamine—Infection—Doxorubicin—sarcoma	0.000734	0.00146	CcSEcCtD
Dinoprost Tromethamine—Shock—Doxorubicin—sarcoma	0.000726	0.00145	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Doxorubicin—sarcoma	0.000721	0.00144	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Epirubicin—sarcoma	0.000717	0.00143	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Doxorubicin—sarcoma	0.000714	0.00142	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Epirubicin—sarcoma	0.000711	0.00142	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Epirubicin—sarcoma	0.000709	0.00141	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Doxorubicin—sarcoma	0.00069	0.00137	CcSEcCtD
Dinoprost Tromethamine—Pain—Epirubicin—sarcoma	0.000682	0.00136	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Doxorubicin—sarcoma	0.000663	0.00132	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Doxorubicin—sarcoma	0.000658	0.00131	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Epirubicin—sarcoma	0.000658	0.00131	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Doxorubicin—sarcoma	0.000656	0.00131	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Epirubicin—sarcoma	0.000653	0.0013	CcSEcCtD
Dinoprost Tromethamine—Pain—Doxorubicin—sarcoma	0.000631	0.00126	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Epirubicin—sarcoma	0.000631	0.00126	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Epirubicin—sarcoma	0.000631	0.00126	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Doxorubicin—sarcoma	0.000608	0.00121	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000604	0.0012	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Epirubicin—sarcoma	0.000588	0.00117	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Doxorubicin—sarcoma	0.000584	0.00116	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Doxorubicin—sarcoma	0.000584	0.00116	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Epirubicin—sarcoma	0.000573	0.00114	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Epirubicin—sarcoma	0.000565	0.00112	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Epirubicin—sarcoma	0.000546	0.00109	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Doxorubicin—sarcoma	0.000544	0.00108	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Doxorubicin—sarcoma	0.00053	0.00106	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Epirubicin—sarcoma	0.000528	0.00105	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Doxorubicin—sarcoma	0.000522	0.00104	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Epirubicin—sarcoma	0.000507	0.00101	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Doxorubicin—sarcoma	0.000505	0.00101	CcSEcCtD
Dinoprost Tromethamine—Rash—Epirubicin—sarcoma	0.000503	0.001	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Epirubicin—sarcoma	0.000503	0.001	CcSEcCtD
Dinoprost Tromethamine—Headache—Epirubicin—sarcoma	0.0005	0.000996	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Doxorubicin—sarcoma	0.000488	0.000972	CcSEcCtD
Dinoprost Tromethamine—Nausea—Epirubicin—sarcoma	0.000474	0.000944	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Doxorubicin—sarcoma	0.000469	0.000935	CcSEcCtD
Dinoprost Tromethamine—Rash—Doxorubicin—sarcoma	0.000466	0.000927	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Doxorubicin—sarcoma	0.000465	0.000926	CcSEcCtD
Dinoprost Tromethamine—Headache—Doxorubicin—sarcoma	0.000463	0.000921	CcSEcCtD
Dinoprost Tromethamine—Nausea—Doxorubicin—sarcoma	0.000439	0.000874	CcSEcCtD
Dinoprost Tromethamine—GALR3—Signaling Pathways—TLE1—sarcoma	0.000153	0.00453	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	0.000153	0.00451	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Platelet activation, signaling and aggregation—SRC—sarcoma	0.00015	0.00442	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—sarcoma	0.000147	0.00435	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Platelet activation, signaling and aggregation—VEGFA—sarcoma	0.000146	0.00431	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—CXCR4—sarcoma	0.000141	0.00417	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	0.000136	0.00401	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—sarcoma	0.000134	0.00396	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—VEGFC—sarcoma	0.000129	0.00382	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—CXCR4—sarcoma	0.000128	0.00378	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—CXCR4—sarcoma	0.000127	0.00376	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—sarcoma	0.000127	0.00374	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—ENO2—sarcoma	0.000122	0.0036	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—HBA1—sarcoma	0.000121	0.00357	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—TLE1—sarcoma	0.000119	0.00351	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—CXCR4—sarcoma	0.000115	0.00341	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—sarcoma	0.000108	0.00318	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TLE1—sarcoma	0.000107	0.00317	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—FLT1—sarcoma	0.000103	0.00305	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—PLCG1—sarcoma	0.000103	0.00305	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—PLCG1—sarcoma	0.000102	0.003	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—VEGFC—sarcoma	0.0001	0.00296	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—sarcoma	9.92e-05	0.00293	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CXCR4—sarcoma	9.75e-05	0.00288	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—sarcoma	9.71e-05	0.00287	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—ATF1—sarcoma	9.64e-05	0.00285	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—CXCR4—sarcoma	9.51e-05	0.00281	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—CXCR4—sarcoma	9.31e-05	0.00275	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—CXCR4—sarcoma	9.31e-05	0.00275	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—sarcoma	9.04e-05	0.00267	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—VEGFC—sarcoma	9.03e-05	0.00267	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—sarcoma	8.85e-05	0.00262	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—CREB1—sarcoma	8.84e-05	0.00261	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—IL2—sarcoma	8.83e-05	0.00261	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—CXCR4—sarcoma	8.63e-05	0.00255	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—sarcoma	8.54e-05	0.00252	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—CXCR4—sarcoma	8.45e-05	0.0025	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—CXCR4—sarcoma	8.45e-05	0.0025	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—sarcoma	8.36e-05	0.00247	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—FLT1—sarcoma	8.01e-05	0.00237	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TLE1—sarcoma	8.01e-05	0.00237	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—PLCG1—sarcoma	7.87e-05	0.00233	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TLE1—sarcoma	7.84e-05	0.00232	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TLE1—sarcoma	7.84e-05	0.00232	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—SRC—sarcoma	7.71e-05	0.00228	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—IGF1R—sarcoma	7.57e-05	0.00224	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CXCR4—sarcoma	7.56e-05	0.00224	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—VEGFA—sarcoma	7.51e-05	0.00222	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—ATF1—sarcoma	7.48e-05	0.00221	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—NRAS—sarcoma	7.41e-05	0.00219	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—sarcoma	7.26e-05	0.00215	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—FLT1—sarcoma	7.22e-05	0.00214	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—FOXO1—sarcoma	7.2e-05	0.00213	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—IL2—sarcoma	7.2e-05	0.00213	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—PDGFRB—sarcoma	7.19e-05	0.00213	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmission across Chemical Synapses—CREB1—sarcoma	7.17e-05	0.00212	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—sarcoma	7.1e-05	0.0021	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PLCG1—sarcoma	7.1e-05	0.0021	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—PDGFRA—sarcoma	7.08e-05	0.00209	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—CREB1—sarcoma	6.86e-05	0.00203	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CXCR4—sarcoma	6.82e-05	0.00202	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—VEGFC—sarcoma	6.76e-05	0.002	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—ATF1—sarcoma	6.74e-05	0.00199	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—VEGFC—sarcoma	6.61e-05	0.00196	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—VEGFC—sarcoma	6.61e-05	0.00196	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—IL2—sarcoma	6.54e-05	0.00193	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—KRAS—sarcoma	6.38e-05	0.00189	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—CREB1—sarcoma	6.18e-05	0.00183	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—KDR—sarcoma	5.96e-05	0.00176	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmission across Chemical Synapses—MDM2—sarcoma	5.93e-05	0.00175	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—IGF1R—sarcoma	5.87e-05	0.00173	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—IL2—sarcoma	5.83e-05	0.00172	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—TP53—sarcoma	5.67e-05	0.00168	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—FOXO1—sarcoma	5.58e-05	0.00165	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—IL2—sarcoma	5.58e-05	0.00165	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—PDGFRB—sarcoma	5.57e-05	0.00165	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—CREB1—sarcoma	5.49e-05	0.00162	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—KIT—sarcoma	5.49e-05	0.00162	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—PDGFRA—sarcoma	5.49e-05	0.00162	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—NRAS—sarcoma	5.49e-05	0.00162	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—HRAS—sarcoma	5.42e-05	0.0016	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—FLT1—sarcoma	5.4e-05	0.0016	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PLCG1—sarcoma	5.31e-05	0.00157	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—IGF1R—sarcoma	5.29e-05	0.00156	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—FLT1—sarcoma	5.29e-05	0.00156	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—FLT1—sarcoma	5.29e-05	0.00156	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CREB1—sarcoma	5.22e-05	0.00154	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PLCG1—sarcoma	5.2e-05	0.00154	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PLCG1—sarcoma	5.2e-05	0.00154	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CXCR4—sarcoma	5.1e-05	0.00151	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—SRC—sarcoma	5.09e-05	0.0015	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—IL2—sarcoma	5.07e-05	0.0015	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—ATF1—sarcoma	5.04e-05	0.00149	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—FOXO1—sarcoma	5.04e-05	0.00149	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—IL2—sarcoma	5.04e-05	0.00149	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PDGFRB—sarcoma	5.03e-05	0.00149	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—EGFR—sarcoma	5e-05	0.00148	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CXCR4—sarcoma	4.99e-05	0.00148	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CXCR4—sarcoma	4.99e-05	0.00148	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—VEGFA—sarcoma	4.96e-05	0.00147	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PDGFRA—sarcoma	4.95e-05	0.00146	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—ATF1—sarcoma	4.94e-05	0.00146	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—ATF1—sarcoma	4.94e-05	0.00146	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—NRAS—sarcoma	4.9e-05	0.00145	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—KRAS—sarcoma	4.72e-05	0.0014	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—CREB1—sarcoma	4.62e-05	0.00137	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—KDR—sarcoma	4.62e-05	0.00137	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—IL2—sarcoma	4.57e-05	0.00135	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—MDM2—sarcoma	4.55e-05	0.00134	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—CREB1—sarcoma	4.53e-05	0.00134	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—CREB1—sarcoma	4.53e-05	0.00134	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—MDM2—sarcoma	4.32e-05	0.00128	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—KIT—sarcoma	4.26e-05	0.00126	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—NRAS—sarcoma	4.26e-05	0.00126	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—KRAS—sarcoma	4.21e-05	0.00125	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—KDR—sarcoma	4.17e-05	0.00123	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CREB1—sarcoma	4.05e-05	0.0012	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—HRAS—sarcoma	4.01e-05	0.00119	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—IGF1R—sarcoma	3.96e-05	0.00117	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—EGFR—sarcoma	3.88e-05	0.00115	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—IGF1R—sarcoma	3.87e-05	0.00115	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—IGF1R—sarcoma	3.87e-05	0.00115	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—IL2—sarcoma	3.86e-05	0.00114	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—KIT—sarcoma	3.84e-05	0.00113	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—NRAS—sarcoma	3.84e-05	0.00113	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—FOXO1—sarcoma	3.77e-05	0.00111	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—IL2—sarcoma	3.77e-05	0.00111	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CCND1—sarcoma	3.76e-05	0.00111	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PDGFRB—sarcoma	3.76e-05	0.00111	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—JUN—sarcoma	3.76e-05	0.00111	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—TP53—sarcoma	3.74e-05	0.00111	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CTNNB1—sarcoma	3.73e-05	0.0011	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PDGFRA—sarcoma	3.7e-05	0.00109	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—FOXO1—sarcoma	3.69e-05	0.00109	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—FOXO1—sarcoma	3.69e-05	0.00109	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—IL2—sarcoma	3.69e-05	0.00109	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—IL2—sarcoma	3.69e-05	0.00109	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PDGFRB—sarcoma	3.68e-05	0.00109	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PDGFRB—sarcoma	3.68e-05	0.00109	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—KRAS—sarcoma	3.66e-05	0.00108	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CREB1—sarcoma	3.65e-05	0.00108	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PDGFRA—sarcoma	3.62e-05	0.00107	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PDGFRA—sarcoma	3.62e-05	0.00107	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—HRAS—sarcoma	3.58e-05	0.00106	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—EGFR—sarcoma	3.5e-05	0.00103	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—IL2—sarcoma	3.42e-05	0.00101	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—SRC—sarcoma	3.37e-05	0.000996	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—MDM2—sarcoma	3.35e-05	0.000991	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—IL2—sarcoma	3.35e-05	0.000989	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—IL2—sarcoma	3.35e-05	0.000989	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—KRAS—sarcoma	3.3e-05	0.000977	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—VEGFA—sarcoma	3.28e-05	0.00097	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmission across Chemical Synapses—HRAS—sarcoma	3.26e-05	0.000962	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—NRAS—sarcoma	3.24e-05	0.000958	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—ENO2—sarcoma	3.17e-05	0.000937	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—HBA1—sarcoma	3.15e-05	0.000931	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—KDR—sarcoma	3.12e-05	0.000921	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—HRAS—sarcoma	3.11e-05	0.00092	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—KDR—sarcoma	3.05e-05	0.000902	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—KDR—sarcoma	3.05e-05	0.000902	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—MDM2—sarcoma	3.02e-05	0.000894	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—MYC—sarcoma	3.02e-05	0.000893	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—IL2—sarcoma	2.99e-05	0.000885	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—EGFR—sarcoma	2.95e-05	0.000873	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CCND1—sarcoma	2.92e-05	0.000863	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—JUN—sarcoma	2.91e-05	0.000861	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CTNNB1—sarcoma	2.89e-05	0.000855	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—KIT—sarcoma	2.87e-05	0.000849	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—NRAS—sarcoma	2.87e-05	0.000849	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—KIT—sarcoma	2.81e-05	0.000831	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—KIT—sarcoma	2.81e-05	0.000831	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—NRAS—sarcoma	2.81e-05	0.000831	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—NRAS—sarcoma	2.81e-05	0.000831	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—HRAS—sarcoma	2.81e-05	0.00083	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—KRAS—sarcoma	2.79e-05	0.000825	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CREB1—sarcoma	2.73e-05	0.000808	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—IL2—sarcoma	2.7e-05	0.000799	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PLCG1—sarcoma	2.69e-05	0.000795	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CREB1—sarcoma	2.67e-05	0.000791	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CREB1—sarcoma	2.67e-05	0.000791	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CCND1—sarcoma	2.63e-05	0.000778	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—JUN—sarcoma	2.63e-05	0.000777	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—EGFR—sarcoma	2.61e-05	0.000773	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—SRC—sarcoma	2.61e-05	0.000773	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CTNNB1—sarcoma	2.61e-05	0.000771	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—EGFR—sarcoma	2.56e-05	0.000757	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—EGFR—sarcoma	2.56e-05	0.000757	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—VEGFA—sarcoma	2.54e-05	0.000752	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—NRAS—sarcoma	2.51e-05	0.000743	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—HRAS—sarcoma	2.49e-05	0.000737	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—TP53—sarcoma	2.48e-05	0.000733	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—KRAS—sarcoma	2.47e-05	0.00073	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—KRAS—sarcoma	2.42e-05	0.000715	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—KRAS—sarcoma	2.42e-05	0.000715	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—HRAS—sarcoma	2.37e-05	0.000701	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—SRC—sarcoma	2.36e-05	0.000697	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—MYC—sarcoma	2.34e-05	0.000692	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—VEGFA—sarcoma	2.3e-05	0.000679	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—EGFR—sarcoma	2.29e-05	0.000677	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—NRAS—sarcoma	2.27e-05	0.00067	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MDM2—sarcoma	2.26e-05	0.000668	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MDM2—sarcoma	2.21e-05	0.000654	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MDM2—sarcoma	2.21e-05	0.000654	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—KRAS—sarcoma	2.16e-05	0.00064	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—MYC—sarcoma	2.11e-05	0.000624	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—HRAS—sarcoma	2.1e-05	0.000621	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—EGFR—sarcoma	2.07e-05	0.000611	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—HRAS—sarcoma	2.06e-05	0.000608	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—HRAS—sarcoma	2.06e-05	0.000608	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—IL2—sarcoma	2.02e-05	0.000597	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—IL2—sarcoma	1.98e-05	0.000585	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—IL2—sarcoma	1.98e-05	0.000585	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CCND1—sarcoma	1.97e-05	0.000582	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—JUN—sarcoma	1.96e-05	0.000581	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—KRAS—sarcoma	1.95e-05	0.000577	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CTNNB1—sarcoma	1.95e-05	0.000576	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CCND1—sarcoma	1.93e-05	0.00057	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CCND1—sarcoma	1.93e-05	0.00057	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—JUN—sarcoma	1.92e-05	0.000569	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—JUN—sarcoma	1.92e-05	0.000569	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—TP53—sarcoma	1.92e-05	0.000569	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CTNNB1—sarcoma	1.91e-05	0.000564	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CTNNB1—sarcoma	1.91e-05	0.000564	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—HRAS—sarcoma	1.84e-05	0.000544	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—SRC—sarcoma	1.76e-05	0.000521	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TP53—sarcoma	1.73e-05	0.000513	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—SRC—sarcoma	1.73e-05	0.00051	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—SRC—sarcoma	1.73e-05	0.00051	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—VEGFA—sarcoma	1.72e-05	0.000507	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—NRAS—sarcoma	1.7e-05	0.000501	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—VEGFA—sarcoma	1.68e-05	0.000497	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—VEGFA—sarcoma	1.68e-05	0.000497	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—NRAS—sarcoma	1.66e-05	0.000491	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—NRAS—sarcoma	1.66e-05	0.000491	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—HRAS—sarcoma	1.66e-05	0.00049	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MYC—sarcoma	1.58e-05	0.000467	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MYC—sarcoma	1.55e-05	0.000457	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MYC—sarcoma	1.55e-05	0.000457	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—EGFR—sarcoma	1.54e-05	0.000457	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—EGFR—sarcoma	1.51e-05	0.000447	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—EGFR—sarcoma	1.51e-05	0.000447	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—KRAS—sarcoma	1.46e-05	0.000431	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—KRAS—sarcoma	1.43e-05	0.000422	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—KRAS—sarcoma	1.43e-05	0.000422	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TP53—sarcoma	1.3e-05	0.000383	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TP53—sarcoma	1.27e-05	0.000375	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TP53—sarcoma	1.27e-05	0.000375	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—HRAS—sarcoma	1.24e-05	0.000367	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—HRAS—sarcoma	1.21e-05	0.000359	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—HRAS—sarcoma	1.21e-05	0.000359	CbGpPWpGaD
